Episode
192: Are you a millennial thinking about menopause?
- Podcast
- The Hotflash inc podcast
- Published
- Jan 8, 2026
- Duration seconds
- 1494
- Processing state
not_requested- Canonical source
- http://www.hotflashinc.com
Actions
POST https://stenobird.com/v1/public/podcasts/the-hotflash-inc-podcast-4524774/episodes/192-are-you-a-millennial-thinking-about-menopause/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-hotflash-inc-podcast-4524774/192-are-you-a-millennial-thinking-about-menopause.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Send a text Journalist and Hotflash inc founder Ann Marie McQueen welcomes Lauren Tetenbaum, aka The Counselaur – a licensed social worker, former lawyer, and author of Millennial Menopause: Preparing for Perimenopause, Menopause, and Life’s Next Period . At 40, Lauren brings a fresh, younger perspective to a conversation that's long left her generation out. Ann Marie and Lauren dive into what it means to enter perimenopause as a millennial – through the lens of mental health, trauma, hormone therapy, supplements, shame, IVF, and what the next generation (Gen Z) might face. Lauren’s unique background in law, therapy, and women’s rights advocacy makes her a powerful voice in this space. Through her private practice and corporate workshops, she supports women navigating life transitions – including the often-misunderstood onset of perimenopause. Fact Check: During this discussion we explore breast cancer risk and hormone therapy, including the distinction between bioidentical progesterone and synthetic progestins. It's essential to understand the difference: Across the strongest randomized evidence from the Women’s Health Initiative (WHI), combined estrogen plus synthetic progestin is associated with a 25–30% relative increase in breast cancer incidence – roughly 8 extra cases per 10,000 women per year in the original WHI report. More recent large observational datasets suggest a higher risk with combined therapy, especially with longer-term use. Combined estrogen with bioidentical progesterone (oral micronized progesterone) has not been shown to carry the same level of risk, though more research is needed. Highlights: –Lauren explains why she wrote Millennial Menopause at 40 How her law and social work background blend in advocacy and therapy Why most millennials are st…